Treatment Needs Often Unmet for Generalized Pustular Psoriasis
Patients with flares more likely to have inpatient, emergency department visits
Dermatological Disorders
Zoryve Cream Now Available for Plaque Psoriasis
Zoryve is supplied in a 60g tube containing 3mg (0.3%) of roflumilast per gram.
Companies Selling Unapproved Drugs for Mole, Skin Tag Removal Get FDA Warning Letter
The Companies are in violation of the FD&C Act, as these products are being marketed with unauthorized claims to remove lesions, including moles and skin tags.
Clinical Challenge: Bump Under Nose
A 17-year-old adolescent is requesting removal of a growth under his nose. Can you make the correct diagnosis?
MPR Weekly Dose Podcast #125
A neurostimulation device has been cleared for post-C-section pain; a new plaque psoriasis treatment; the FDA addresses the contrast agent shortage; Lucentis biosimilar treatment is approved; and the recall is expanded for an over-the-counter laxative.
Clinical Challenge: Flesh-Colored Papule Above Lip
A 76-year-old Black woman presents to the clinic for evaluation of a bump on her face that she first noticed about a year ago. Can you make the correct diagnosis?
Juvéderm Volux XC Approved for Improving Jawline Definition
Juvéderm Volux XC is an injectable gel filler containing hyaluronic acid.
FDA to Review Resubmitted Application for Severe Burn Therapy NexoBrid
NexoBrid is a topically administered, bromelain-based biological product containing a sterile mixture of proteolytic enzymes.
Study Investigating Oral JAK Inhibitor for Alopecia Areata Meets Endpoint
CTP-543 is an investigational oral selective inhibitor of JAK1 and JAK2.
